Related Experiment Video
Updated: Apr 27, 2026
Bronchial Thermoplasty: A Novel Therapeutic Approach to Severe Asthma
Published on: November 4, 2010
Magnesium should be given to all children presenting to hospital with acute severe asthma
1Advanced Trainee in Respiratory Medicine and General Paediatrics, The Children's Hospital at Westmead, Sydney.
Insights
Magnesium sulfate is a safe and effective treatment for acute severe asthma in children. Its favorable cost-benefit profile supports its use in all pediatric asthma exacerbations.
Area of Science:
- Pediatric Pulmonology
- Emergency Medicine
Background:
- Asthma is a common chronic childhood illness with frequent acute exacerbations.
- Acute severe asthma requires emergency medical management, often involving corticosteroids and bronchodilators.
Purpose of the Study:
- To evaluate the role of magnesium sulfate in managing acute severe asthma in children.
- To address the inconsistent use of magnesium sulfate due to lack of consensus.
Main Methods:
- Review of accumulating evidence on magnesium sulfate efficacy and safety.
- Assessment of inhaled and intravenous magnesium sulfate administration routes.
Main Results:
- Magnesium sulfate demonstrates a favorable safety profile and effectiveness in reversing bronchoconstriction.
- Evidence suggests a positive 'cost-benefit' profile for magnesium sulfate therapy.
Conclusions:
- The evidence supports the use of magnesium sulfate as an adjunct therapy for acute severe asthma in children.
- Widespread adoption of magnesium sulfate for all pediatric acute severe asthma cases is justified based on current data.
Abstract:
Asthma is one of the most prevalent chronic condition affecting children worldwide and acute exacerbations requiring emergency medical management are common. In addition to corticosteroids, a number of drugs may be used in the management of acute severe asthma aiming to reverse bronchoconstriction. Magnesium sulphate - either inhaled or intravenous - may be added to conventional therapy of children with acute severe asthma. Despite its safety profile and effectiveness, the use of magnesium sulphate has been inconsistent due to lack of consensus. The authors believe that the accumulating evidence of a favorable 'cost benefit' profile justifies the use of magnesium for all children presenting with acute severe asthma.
Related Concept Videos
01:30Asthma-IV: Diagnostic and Management
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
01:25Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
01:24Antiasthma Drugs: Methylxanthines
Theophylline is thought to inhibit phosphodiesterase enzymes, increasing intracellular levels of cyclic adenosine monophosphate (cAMP) and cyclic guanosine monophosphate (cGMP). This rise in cAMP and cGMP concentrations stimulates cardiac function,...
01:19Antiasthma Drugs: Leukotriene Modifiers
Leukotriene modifiers work through two distinct mechanisms:
01:25Antiasthma Drugs: β2-Adrenoceptor Agonists
One class of bronchodilators includes β2-adrenoceptor agonists. These agents target the β2-adrenoceptors located on bronchial smooth muscle cells. By stimulating these receptors, β2-agonists induce...
01:20Antiasthma Drugs: Muscarinic Receptor Antagonists
Antimuscarinic agents compete with ACh for the same binding site on the muscarinic receptors. By binding to these receptors, they inhibit the downstream effects of ACh and block the parasympathetic...